219 related articles for article (PubMed ID: 29656267)
1. A naturalistic examination of the perceived effects of cannabis on negative affect.
Cuttler C; Spradlin A; McLaughlin RJ
J Affect Disord; 2018 Aug; 235():198-205. PubMed ID: 29656267
[TBL] [Abstract][Full Text] [Related]
2. Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis.
Haney M; Malcolm RJ; Babalonis S; Nuzzo PA; Cooper ZD; Bedi G; Gray KM; McRae-Clark A; Lofwall MR; Sparenborg S; Walsh SL
Neuropsychopharmacology; 2016 Jul; 41(8):1974-82. PubMed ID: 26708108
[TBL] [Abstract][Full Text] [Related]
3. Does medicinal cannabis affect depression, anxiety, and stress in people with cancer? A systematic review and meta-analysis of intervention studies.
Crichton M; Dissanayaka T; Marx W; Gamage E; Travica N; Bowers A; Isenring E; Yates P; Marshall S
Maturitas; 2024 Jun; 184():107941. PubMed ID: 38430618
[TBL] [Abstract][Full Text] [Related]
4. Baseline affective symptomatology moderates acute subjective effects of high potency THC and CBD cannabis concentrates.
Martin-Willett R; Skrzynski CJ; Karoly HC; Elmore JS; Bidwell LC
Exp Clin Psychopharmacol; 2023 Dec; 31(6):1039-1049. PubMed ID: 37289543
[TBL] [Abstract][Full Text] [Related]
5. Evaluating cannabidiol (CBD) expectancy effects on acute stress and anxiety in healthy adults: a randomized crossover study.
Spinella TC; Stewart SH; Naugler J; Yakovenko I; Barrett SP
Psychopharmacology (Berl); 2021 Jul; 238(7):1965-1977. PubMed ID: 33813611
[TBL] [Abstract][Full Text] [Related]
6. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
[TBL] [Abstract][Full Text] [Related]
7. Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress.
Childs E; Lutz JA; de Wit H
Drug Alcohol Depend; 2017 Aug; 177():136-144. PubMed ID: 28599212
[TBL] [Abstract][Full Text] [Related]
8. A Large-Scale Naturalistic Examination of the Acute Effects of Cannabis on Pain.
Cuttler C; LaFrance EM; Craft RM
Cannabis Cannabinoid Res; 2022 Feb; 7(1):93-99. PubMed ID: 33998864
[No Abstract] [Full Text] [Related]
9. Effect of prior foot shock stress and Δ
Rock EM; Limebeer CL; Petrie GN; Williams LA; Mechoulam R; Parker LA
Psychopharmacology (Berl); 2017 Jul; 234(14):2207-2217. PubMed ID: 28424834
[TBL] [Abstract][Full Text] [Related]
10. Cannabidiol in medical marijuana: Research vistas and potential opportunities.
Rong C; Lee Y; Carmona NE; Cha DS; Ragguett RM; Rosenblat JD; Mansur RB; Ho RC; McIntyre RS
Pharmacol Res; 2017 Jul; 121():213-218. PubMed ID: 28501518
[TBL] [Abstract][Full Text] [Related]
11. The effects of cannabidiol (CBD) on Δ⁹-tetrahydrocannabinol (THC) self-administration in male and female Long-Evans rats.
Wakeford AGP; Wetzell BB; Pomfrey RL; Clasen MM; Taylor WW; Hempel BJ; Riley AL
Exp Clin Psychopharmacol; 2017 Aug; 25(4):242-248. PubMed ID: 28682102
[TBL] [Abstract][Full Text] [Related]
12. The Effectiveness of
Li X; Diviant JP; Stith SS; Brockelman F; Keeling K; Hall B; Vigil JM
Yale J Biol Med; 2020 Jun; 93(2):251-264. PubMed ID: 32607086
[No Abstract] [Full Text] [Related]
13. Cannabis Use and Cognition in Adults Prescribed Opioids for Persistent Pain.
Wildes M; Bigand TL; Layton ME; Wilson M
Pain Manag Nurs; 2020 Feb; 21(1):94-99. PubMed ID: 31405787
[TBL] [Abstract][Full Text] [Related]
14. Interactions between cannabidiol and Δ
Todd SM; Zhou C; Clarke DJ; Chohan TW; Bahceci D; Arnold JC
Eur Neuropsychopharmacol; 2017 Feb; 27(2):132-145. PubMed ID: 28043732
[TBL] [Abstract][Full Text] [Related]
15. Short- and Long-Term Effects of Cannabis on Headache and Migraine.
Cuttler C; Spradlin A; Cleveland MJ; Craft RM
J Pain; 2020; 21(5-6):722-730. PubMed ID: 31715263
[TBL] [Abstract][Full Text] [Related]
16. Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders.
García-Gutiérrez MS; Navarrete F; Gasparyan A; Austrich-Olivares A; Sala F; Manzanares J
Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33228239
[TBL] [Abstract][Full Text] [Related]
17. Acute and Extended Anxiolytic Effects of Cannabidiol in Cannabis Flower: A Quasi-Experimental
Bidwell LC; Martin-Willett R; Skrzynski C; Lisano J; Ortiz Torres M; Giordano G; Hutchison KE; Bryan AD
Cannabis Cannabinoid Res; 2024 Jan; ():. PubMed ID: 38252547
[No Abstract] [Full Text] [Related]
18. Effects of ∆
Raymundi AM; da Silva TR; Sohn JMB; Bertoglio LJ; Stern CA
BMC Psychiatry; 2020 Aug; 20(1):420. PubMed ID: 32842985
[TBL] [Abstract][Full Text] [Related]
19. Practical considerations in medical cannabis administration and dosing.
MacCallum CA; Russo EB
Eur J Intern Med; 2018 Mar; 49():12-19. PubMed ID: 29307505
[TBL] [Abstract][Full Text] [Related]
20. An assessment of concurrent cannabidiol and Δ⁹-tetrahydrocannabinol administration in place aversion and taste avoidance conditioning.
Hempel BJ; Clasen MM; Nelson KH; Woloshchuk CJ; Riley AL
Exp Clin Psychopharmacol; 2018 Apr; 26(2):205-213. PubMed ID: 29648861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
